CCC
HUM icon

Crescent Capital Consulting’s Humana HUM Stock Holding History

Crescent Capital Consulting’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2K Hold
5
– – ﹤0.01% 473
2021
Q3 		$2K Hold
5
– – ﹤0.01% 511
2021
Q2 		$2K Hold
5
– – ﹤0.01% 453
2021
Q1 		$2K Hold
5
– – ﹤0.01% 452
2020
Q4 		$2K Buy
+5
New +$2.08K ﹤0.01% 410

Other funds holding HUM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Crescent Capital Consulting's HUM Position: Q4 2021 in Review

Crescent Capital Consulting held its Humana (HUM) position steady in Q4 2021 at 5 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Crescent Capital Consulting first reported a position in HUM in Q4 2020 and has held it in 5 quarters since. 928 funds tracked by Wall St. Rank hold HUM as of Q4 2021.

  • Crescent Capital Consulting held 5 shares of Humana worth $2K as of Q4 2021.
  • Crescent Capital Consulting left its Humana share count unchanged in Q4 2021.
  • Humana made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #473 holding.
  • Crescent Capital Consulting first reported a position in Humana in Q4 2020 and has held it in 5 quarters since.
  • 928 funds tracked by Wall St. Rank held Humana as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.